O(6)-methylguanine-DNA methyltransferase promoter methylation and isocitrate dehydrogenase mutation as prognostic factors in a cohort of Saudi patients with glioblastoma

BACKGROUND: Treatment of glioblastoma (GB), the most common malignant primary brain tumor in adults, can include alkylating chemo-therapeutic agents. Two molecular biomarkers of treatment response are MGMT (O(6)-methylguanine-DNA methyltransferase) promoter methylation and IDH (isocitrate dehydrogen...

Descripción completa

Detalles Bibliográficos
Autores principales: Alassiri, Ali H., Alkhaibary, Ali, Al-Sarheed, Saud, Alsufani, Fahd, Alharbi, Mohammed, Alkhani, Ahmed, Aloraidi, Ahmed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: King Faisal Specialist Hospital and Research Centre 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6894451/
https://www.ncbi.nlm.nih.gov/pubmed/31804140
http://dx.doi.org/10.5144/0256-4947.2019.410

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6894451/
https://www.ncbi.nlm.nih.gov/pubmed/31804140
http://dx.doi.org/10.5144/0256-4947.2019.410

Ejemplares similares